Affiliate Associate Professor, Global Health
Dr. Marianne Mureithi serves as the Chair of the Department of Medical Microbiology & Immunology at the Faculty of Health Sciences, University of Nairobi, Kenya, and as Team Leader at the Kenya AIDS Vaccine Initiative - Institute of Clinical Research (KAVI-ICR). She is also a co-investigator in the ADVANCE program under the International AIDS Vaccine Initiative (IAVI). Her educational background includes degrees from the University of Essex and the University of Bristol, as well as a post-doctoral fellowship from the Ragon Institute of MGH, MIT, and Harvard, USA, and the University of KwaZulu-Natal, SA. Driven by the dream of a world without AIDS, Her research focuses on characterizing the early stages of HIV infection, studying the phenotype of target cells in mucosal tissues, and investigating the establishment of mucosal viral reservoirs, particularly in the female genital tract. She also analyzes biological markers and metabolomics in early HIV infection to support vaccine design and treatment development.
Dr. Mureithi is also actively involved as a lead in the Kenya Research and Training Centre's priority area of Strengthening and Increasing Access to a Network of Facilities and Resources. She is also part of the leadership of the Women's Health Project in Mombasa, which is a collaborative initiative between the University of Nairobi and the University of Washington. The project aims to improve women's health outcomes by conducting research, implementing interventions, and providing comprehensive healthcare services.
Publications
- Ogoti, B, Riitho, V, Wildemann, J, Mutono, N, Mureithi, M, Oyugi, PJ et al.. Epidemiology and genomic features of MERS coronavirus in Africa: a systematic and meta-analysis review. Int J Infect Dis. 2026; :108456. doi: 10.1016/j.ijid.2026.108456. PubMed PMID:41644038 .
- Kahariri, S, Thomas, LF, Bett, B, Mureithi, MW, Makori, A, Njuguna, B et al.. Integrated Surveillance for Human and Animal Brucellosis in Kenya: A Predictive Analysis. Trop Med Infect Dis. 2025;10 (12):. doi: 10.3390/tropicalmed10120344. PubMed PMID:41441582 PubMed Central PMC12737715.
- Kiptinness, C, Mureithi, MW, Osoti, A, Wairimu, N, Githuku, DM, Okello, P et al.. Acceptability of secondary distribution of HIV self-testing kits in central Kenya: a qualitative study on the perspectives of people living with HIV, their sexual partners, and healthcare providers. AIDS Care. 2025; :1-11. doi: 10.1080/09540121.2025.2605486. PubMed PMID:41416962 .
- Langat, R, McRaven, MD, Lorenzo-Redondo, R, Muhomah, T, Carias, AM, Arif, MS et al.. Endocervix exhibits greater susceptibility to HIV-1 infection compared to ectocervix following ex vivo exposure to Transmitted/Founder HIV-1 variants. PLoS One. 2025;20 (11):e0334510. doi: 10.1371/journal.pone.0334510. PubMed PMID:41191579 PubMed Central PMC12588514.
- Kering, K, Njaanake, K, Wairimu, C, Mureithi, M, Kebenei, C, Mbae, C et al.. Azithromycin resistance in nontyphoidal Salmonella in an urban informal settlement in Nairobi, Kenya. Microbiol Spectr. 2025;13 (12):e0098525. doi: 10.1128/spectrum.00985-25. PubMed PMID:41143418 PubMed Central PMC12671183.
